← Eichor
Study identifier: NCT07341464 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Acceptability and Tolerance Study of Bolus Tube Feed With Food Blends

Condition: Cerebral Palsy (CP) · Oncology  ·  Sponsor: Société des Produits Nestlé (SPN)

PhaseNA
Planned participants50
Who can joinAll sexes, 1 Year to no upper limit
Healthy volunteersNo

About this study

This is a prospective acceptability study to evaluate the gastrointestinal tolerance and compliance of a bolus tube feed over a 28 -day period for up to 50 participants. The enteral bolus formula is for the dietary management of patients with short bowel syndrome; intractable malabsorption; preoperative preparation of undernourished patients; inflammatory bowel disease; total gastrectomy; dysphagia; bowel fistulae; feeding intolerances, developmental disabilities, and disease related malnutrition.

This description comes directly from the study's public registry record.

Talk to the study team

Sharan Saduera, BSc (Hons) Dietetics  ·  +447557170649  ·  sharan.saduera@uk.nestle.com

Sarah Durnan, PHD, BSc Nutrition Dietetics

Always discuss trial participation with your own doctor first.

Locations (2)

Queen Medical Hospital Nutrition and DieteticsNottingham, United KingdomNot Yet Recruiting
Dietetic Team 1st floor Kings Court 1, Charles Hastings Way,Worcester, United KingdomRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07341464